Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Attenuation of muscle wasting in murine C2C12myotubes by epigallocatechin-3-gallate

(2014) Kamran A. Mirza et al.   Journal of Cachexia Sarcopenia and Muscle

Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus

(2013) Jia Zhang et al.   BEHAVIOURAL BRAIN RESEARCH

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

(2013) Grace K. Dy et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma

(2013) Yang Quanjun et al.   PHYTOMEDICINE

Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

(2012) Kenneth C.H. Fearon et al.   Cell Metabolism

Salidroside Protects Human Erythrocytes against Hydrogen Peroxide-Induced Apoptosis

(2012) Erin Wei Qian et al.   JOURNAL OF NATURAL PRODUCTS

Understanding the mechanisms and treatment options in cancer cachexia

(2012) Kenneth Fearon et al.   Nature Reviews Clinical Oncology

Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats

(2011) N Deblon et al.   BRITISH JOURNAL OF PHARMACOLOGY

Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia

(2011) Hang Wang et al.   CANCER LETTERS

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Cancer Cachexia and Fat–Muscle Physiology

(2011) Kenneth C.H. Fearon   NEW ENGLAND JOURNAL OF MEDICINE

Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia

(2011) S. K. Das et al.   SCIENCE

Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells

(2010) Li Zhang et al.   NEUROCHEMISTRY INTERNATIONAL

Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy

(2009) Valérie Risson et al.   JOURNAL OF CELL BIOLOGY

Mechanisms of Cancer Cachexia

(2009) Michael J. Tisdale   PHYSIOLOGICAL REVIEWS

Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-α and angiotensin II by β-hydroxy-β-methylbutyrate

(2008) Helen L. Eley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Cachexia: prevalence and impact in medicine

(2008) Benjamin HL Tan et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE